Dr. Koller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
23451 Madison St
Ste 340
Torrance, CA 90505Phone+1 310-373-6864Fax+1 614-293-4030
Education & Training
Ohio State University HospitalResidency, Surgery, 2014 - 2021
McGovern Medical School at UTHealthClass of 2014
Tulane UniversityBS, Cell and Molecular Biology, 2006 - 2010
Certifications & Licensure
CA State Medical License 2022 - 2026
RI State Medical License 2021 - 2023
MA State Medical License 2021 - 2022
OH State Medical License 2014 - 2022- American Board of Surgery Surgery
Publications & Presentations
PubMed
- 18 citationsAutophagy inhibition overcomes sorafenib resistance in S45F-mutated desmoid tumors.Danielle Braggio, David Koller, Feng Jin, Nanda Siva, Abeba Zewdu
Cancer. 2019-08-01 - 18 citationsβ-catenin S45F mutation results in apoptotic resistanceDanielle Braggio, Abeba Zewdu, Abeba Zewdu, Priya Londhe, Peter Y. Yu
Oncogene. 2020-07-10 - 7 citationsPreclinical efficacy of the Wnt/β-catenin pathway inhibitor BC2059 for the treatment of desmoid tumors.Danielle Almeida Braggio, Fernanda Costas C de Faria, David Koller, Feng Jin, Abeba Zewdu
Plos One. 2022-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
